3,4-epithiobutanenitrile has been researched along with acrolein in 1 studies
Studies (3,4-epithiobutanenitrile) | Trials (3,4-epithiobutanenitrile) | Recent Studies (post-2010) (3,4-epithiobutanenitrile) | Studies (acrolein) | Trials (acrolein) | Recent Studies (post-2010) (acrolein) |
---|---|---|---|---|---|
6 | 0 | 4 | 3,386 | 48 | 1,636 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dixon, MJ; Eggleston, IM; Hayes, JD; Kelleher, MO; McMahon, M; Taguchi, K; Yamamoto, M | 1 |
1 other study(ies) available for 3,4-epithiobutanenitrile and acrolein
Article | Year |
---|---|
1-Cyano-2,3-epithiopropane is a novel plant-derived chemopreventive agent which induces cytoprotective genes that afford resistance against the genotoxic alpha,beta-unsaturated aldehyde acrolein.
Topics: Acrolein; Animals; Antioxidants; Cell Survival; Epithelial Cells; Genes, Reporter; Glucosinolates; Glutathione; Liver; Luciferases; Mice; Nitriles; Plant Extracts; Propane; Rats; RNA, Messenger; Sulfhydryl Compounds; Transcription, Genetic | 2009 |